Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Platelet rich plasma is as effective as triamcinolone for treating alopecia areata.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Topical immunotherapy with SADBE and DPCP is most effective for short-term hair regrowth in children with severe alopecia areata.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

0.05% betamethasone dipropionate is the most effective treatment for mild alopecia areata.

Co-trimoxazole may help treat autoimmune diseases.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Ro 10-9359 is an effective treatment for severe psoriasis but can cause side effects.

Smaller, diluted corticosteroid injections reduce the risk of vision loss.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Tofacitinib may help treat hair loss in children with alopecia areata.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

The adapalene-benzoyl peroxide gel works better and faster for acne treatment than using either ingredient alone, with manageable side effects.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.